Uludağ University Faculty of Medicine, Department of Pediatric Hematology, Bursa, Turkey
Dokuz Eylül University Faculty of Medicine, Department of Pediatric Hematology, İzmir, Turkey
Turk J Haematol. 2022 Jun 1;39(2):94-102. doi: 10.4274/tjh.galenos.2021.2021.0203. Epub 2021 Nov 18.
The incidence of invasive fungal infections (IFIs) has increased due to intensive chemotherapy in childhood leukemia. The aim of this study was to evaluate the incidence, risk factors, causative pathogens, and impact on survival of IFIs among pediatric leukemia patients.
The hospital records of 307 children with acute lymphoblastic leukemia (ALL, n=238), acute myeloid leukemia (AML, n=51), and relapsed leukemia (n=18) between January 2010 and December 2015 were retrospectively evaluated.
A total of 1213 febrile neutropenia episodes were recorded and 127 (10.4%) of them were related to an IFI. Of 307 children, 121 (39.4%) developed IFIs. The mean age was significantly older in the IFI group compared to children without IFIs (p<0.001). IFIs were defined as possible, probable, and proven in 73.2%, 11.9%, and 14.9% of the attacks, respectively. Invasive aspergillosis (81.9%) was the most frequent infection, followed by invasive candidiasis (13.4%) and rare fungal diseases (4.8%). The majority of IFI attacks in both ALL and AML occurred during the induction phase. In total, the death rate was 24% and the IFI-related mortality rate was 18%. The mortality rate among children with IFIs was found to be significantly higher than that of children without IFIs (p<0.001). Overall and event-free survival rates at 5 years were also found to be significantly lower in the IFI group (p<0.001). Relapse (odds ratio: 8.49) was the most effective risk factor for mortality, followed by developing an IFI episode (odds ratio: 3.2) and AML (odds ratio: 2.33) according to multivariate regression analysis.
Our data showed that IFIs were more common in older children. Although proven and probable IFI episodes were more frequently diagnosed in cases of relapse and AML, children with ALL and AML had similar frequencies of experiencing at least one episode Conclusion: Our data showed that IFIs were more common in older children. Although proven and probable IFI episodes were more frequently diagnosed in cases of relapse and AML, children with ALL and AML had similar frequencies of experiencing at least one episode
由于儿童白血病的强化化疗,侵袭性真菌感染(IFI)的发病率有所增加。本研究旨在评估儿科白血病患者IFI的发生率、危险因素、病原体和对生存的影响。
回顾性分析 2010 年 1 月至 2015 年 12 月间 307 例急性淋巴细胞白血病(ALL,n=238)、急性髓细胞白血病(AML,n=51)和复发白血病(n=18)患儿的住院记录。
共记录了 1213 例发热性中性粒细胞减少症发作,其中 127 例(10.4%)与 IFI 有关。307 例患儿中,121 例(39.4%)发生 IFI。IFI 组的平均年龄明显大于无 IFI 组(p<0.001)。IFI 分别被定义为可能、可能和确诊,分别占 73.2%、11.9%和 14.9%。侵袭性曲霉菌病(81.9%)是最常见的感染,其次是侵袭性念珠菌病(13.4%)和罕见真菌病(4.8%)。ALL 和 AML 中的大多数 IFI 发作发生在诱导期。共有 24%的患儿死亡,IFI 相关死亡率为 18%。IFI 患儿的死亡率明显高于无 IFI 患儿(p<0.001)。IFI 组的总体和无事件生存率也明显低于无 IFI 组(p<0.001)。根据多变量回归分析,复发(比值比:8.49)是死亡的最有效危险因素,其次是发生 IFI 发作(比值比:3.2)和 AML(比值比:2.33)。
我们的数据表明,IFI 在年龄较大的儿童中更为常见。尽管在复发和 AML 中更常诊断出确诊和可能的 IFI 发作,但 ALL 和 AML 患儿经历至少一次发作的频率相似。